Subclinical vitamin D deficiency

被引:38
作者
Cianferotti, Luisella [1 ]
Marcocci, Claudio [1 ]
机构
[1] Univ Pisa, Univ Hosp Pisa, Dept Endocrinol & Metab, Unit Endocrinol & Bone Metab, I-56124 Pisa, Italy
关键词
25OHD; insufficiency; rickets; osteomalacia; cancer; muscle; diabetes; falls; fractures; SERUM 25-HYDROXYVITAMIN D; LOWER-EXTREMITY FUNCTION; BONE-MINERAL DENSITY; D SUPPLEMENTATION; DOUBLE-BLIND; CALCIUM SUPPLEMENTATION; PARATHYROID-HORMONE; HYPOVITAMINOSIS-D; D INSUFFICIENCY; US POPULATION;
D O I
10.1016/j.beem.2011.12.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The optimal vitamin D status, as defined by serum 25-hydroxy-vitamin D [25(OH)D], is still controversial. Some individuals are at risk for subclinical vitamin D deficiency, as defined by serum 25(OH)D levels between 25 and 75 nmol/L, and up to 80-100% of the entire population can display inadequate serum 25(OH)D values depending on latitude and seasonality. The clinical manifestation of extreme vitamin D deficiency, i.e. rickets and osteomalacia, are rare. Levels of 25(OH)D >= 50 nmol/L are required for optimal musculoskeletal health. However, levels of 25(OH)D above 75 nmol/L may be necessary to maximize musculoskeletal benefits and take advantage of the extraskeletal actions of vitamin D. This review will summarize the actual positions on the boundaries of subclinical vitamin D deficiency, the main available evidence on the effects of inadequate vitamin D status on skeletal and extraskeletal targets and supplementation strategies. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:523 / 537
页数:15
相关论文
共 83 条
[1]   A Phase 2 Trial Exploring the Effects of High-Dose (10,000 IU/Day) Vitamin D3 in Breast Cancer Patients With Bone Metastases [J].
Amir, Eitan ;
Simmons, Christine E. ;
Freedman, Orit C. ;
Dranitsaris, George ;
Cole, David E. C. ;
Vieth, Reinhold ;
Ooi, Wei S. ;
Clemons, Mark .
CANCER, 2010, 116 (02) :284-291
[2]  
[Anonymous], 2011, DIETARY REFERENCE IN
[3]   CORRELATION OF SYMPTOMS WITH VITAMIN D DEFICIENCY AND SYMPTOM RESPONSE TO CHOLECALCIFEROL TREATMENT: A RANDOMIZED CONTROLLED TRIAL [J].
Arvold, David S. ;
Odean, Marilyn J. ;
Dornfeld, Maude P. ;
Regal, Ronald R. ;
Arvold, Judith G. ;
Karwoski, Gene C. ;
Mast, David J. ;
Sanford, Paul B. ;
Sjoberg, Robert J. .
ENDOCRINE PRACTICE, 2009, 15 (03) :203-212
[4]   Vitamin D supplementation and total mortality - A meta-analysis of randomized controlled trials [J].
Autier, Philippe ;
Gandini, Sara .
ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (16) :1730-1737
[5]   Nonclassic Actions of Vitamin D [J].
Bikle, Daniel .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (01) :26-34
[6]   Correlation among 25-hydroxy-vitamin D assays [J].
Binkley, N. ;
Krueger, D. ;
Gemar, D. ;
Drezner, M. K. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (05) :1804-1808
[7]   Assay variation confounds the diagnosis of hypovitaminosis D: A call for standardization [J].
Binkley, N ;
Krueger, D ;
Cowgill, CS ;
Plum, L ;
Lake, E ;
Hansen, KE ;
DeLuca, HF ;
Drezner, MK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07) :3152-3157
[8]   Evaluation of Ergocalciferol or Cholecalciferol Dosing, 1,600 IU Daily or 50,000 IU Monthly in Older Adults [J].
Binkley, N. ;
Gemar, D. ;
Engelke, J. ;
Gangnon, R. ;
Ramamurthy, R. ;
Krueger, D. ;
Drezner, M. K. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04) :981-988
[9]   Benefit-risk assessment of vitamin D supplementation [J].
Bischoff-Ferrari, H. A. ;
Shao, A. ;
Dawson-Hughes, B. ;
Hathcock, J. ;
Giovannucci, E. ;
Willett, W. C. .
OSTEOPOROSIS INTERNATIONAL, 2010, 21 (07) :1121-1132
[10]   Positive association between 25-hydroxy, vitamin D levels and bone mineral density: A population-based study of younger and older adults [J].
Bischoff-Ferrari, HA ;
Dietrich, T ;
Orav, EJ ;
Dawson-Hughes, B .
AMERICAN JOURNAL OF MEDICINE, 2004, 116 (09) :634-639